Christopher Yea, CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 14,204 shares at $12.01 ($171K) on 2024-08-19, disclosed to the SEC on 2024-08-21.
Seasonal sale ($171k) by CHIEF DEVELOPMENT OFFICER — this insider has traded KALV in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.01 | 7,102 | $85K | 50.0% |
| 2 | $12.01 | 7,102 | $85K | 50.0% |
| Total | $12.01 avg | 14,204 | $171K | 100% |
| Filing → |
| KALV | SELL | 2026-05-26 | $63K | — | Filing → |
| KALV | SELL | 2026-05-19 | $30K | — | Filing → |
| KALV | SELL | 2026-02-24 | $68K | — | Filing → |